高级检索
当前位置: 首页 > 详情页

Acupuncture for cancer pain: an evidence-based clinical practice guideline.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Social Medicine and Health Management, School of PublicHealth, Lanzhou University, Lanzhou, China [2]Evidence Based Social ScienceResearch Centre, School of Public Health, Lanzhou University, Lanzhou, China [3]WHO Collaborating Center for Guideline Implementation and KnowledgeTranslation, Lanzhou, China [4]Chinese GRADE Centre, Lanzhou University,Lanzhou, China [5]Guangdong Provincial Hospital of Chinese Medicine,Guangzhou, China [6]The Second Affiliated Hospital of Guangzhou Universityof Chinese Medicine, Guangzhou, China [7]Guangdong Provincial Academyof Chinese Medical Sciences, Guangzhou, China [8]Evidence‑Based MedicineCenter, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China [9]South China Research Center for Acupuncture and Moxibustion, MedicalCollege of Acu‑Moxi and Rehabilitation, Guangzhou University of ChineseMedicine, Guangzhou, China [10]Key Laboratory of Evidence Based Medicineand Knowledge Translation of Gansu Province, Lanzhou, China [11]China‑AustraliaInternational Research Centre for Chinese Medicine, School of Healthand Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia [12]Oncology Department of Bayi Hospital, Nanjing University of ChineseMedicine, Nanjing, China [13]The Third Affiliated Hospital, Beijing Universityof Chinese Medicine, Beijing, China [14]Center for East‑West Medicine, Departmentof Medicine, David Geffen School of Medicine, University of California,Los Angeles, Santa Monica, USA [15]Chengdu University of Traditional ChineseMedicine, Chengdu, China [16]Beijing Hospital of Traditional Chinese Medicine,Capital Medical University, Beijing, China [17]Key Laboratory of Acupunctureand Medicine Research of Ministry of Education, Nanjing University of ChineseMedicine, Nanjing, China [18]Department of Oncology, Xiyuan Hospital, ChinaAcademy of Chinese Medical Sciences, Beijing, China [19]Department of Oncology,Southern Theater Command General Hospital of PLA, Guangzhou,China [20]School of Traditional Chinese Medicine, Beijing University of ChineseMedicine, Beijing, China [21]Institute of Acupuncture and Moxibustion, ChinaAcademy of Chinese Medicine Sciences, Beijing, China
出处:
ISSN:

关键词: Acupuncture Cancer pain Practice guideline Evidence-based practice

摘要:
This study aims to develop an evidence-based clinical practice guideline of acupuncture in the treatment of patients with moderate and severe cancer pain.The development of this guideline was triggered by a systematic review published in JAMA Oncology in 2020. We searched databases and websites for evidence on patient preferences and values, and other resources of using acupuncture for treatment of cancer pain. Recommendations were developed through a Delphi consensus of an international multidisciplinary panel including 13 western medicine oncologists, Chinese medicine/acupuncture clinical practitioners, and two patient representatives. The certainty of evidence, patient preferences and values, resources, and other factors were fully considered in formulating the recommendations. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was employed to rate the certainty of evidence and the strength of recommendations.The guideline proposed three recommendations: (1) a strong recommendation for the treatment of acupuncture rather than no treatment to relieve pain in patients with moderate to severe cancer pain; (2) a weak recommendation for the combination treatments with acupuncture/acupressure to reduce pain intensity, decrease the opioid dose, and alleviate opioid-related side effects in moderate to severe cancer pain patients who are using analgesics; and (3) a strong recommendation for acupuncture in breast cancer patients to relieve their aromatase inhibitor-induced arthralgia.This proposed guideline provides recommendations for the management of patients with cancer pain. The small sample sizes of evidence limit the strength of the recommendations and highlights the need for additional research.© 2022. The Author(s).

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 2 区 全科医学与补充医学 3 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 全科医学与补充医学 2 区 药学
JCR分区:
出版当年[2020]版:
Q1 PHARMACOLOGY & PHARMACY Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
最新[2023]版:
Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Social Medicine and Health Management, School of PublicHealth, Lanzhou University, Lanzhou, China [2]Evidence Based Social ScienceResearch Centre, School of Public Health, Lanzhou University, Lanzhou, China [3]WHO Collaborating Center for Guideline Implementation and KnowledgeTranslation, Lanzhou, China [4]Chinese GRADE Centre, Lanzhou University,Lanzhou, China
共同第一作者:
通讯作者:
通讯机构: [5]Guangdong Provincial Hospital of Chinese Medicine,Guangzhou, China [6]The Second Affiliated Hospital of Guangzhou Universityof Chinese Medicine, Guangzhou, China [7]Guangdong Provincial Academyof Chinese Medical Sciences, Guangzhou, China [11]China‑AustraliaInternational Research Centre for Chinese Medicine, School of Healthand Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号